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Abstract
Protein kinase C iota is required for various cell biological processes including epithelial tissue polarity and organ
morphogenesis. To gain mechanistic insight into different roles of this kinase, it is essential to identify specific substrate
proteins in their cellular context. The analog-sensitive kinase method provides a powerful tool for the identification of
kinase substrates under in vivo conditions. However, it has remained a major challenge to establish screens based on this
method in multicellular model organisms. Here, we report the methodology for in vivo conditions using the analog-sensitive
kinase method in a genetically-tractable vertebrate model organism, the zebrafish. With this approach, kinase substrates can
uniquely be labeled in the developing zebrafish embryo using bulky ATPcS analogs which results in the thiopho-
sphorylation of substrates. The labeling of kinase substrates with a thiophosphoester epitope differs from phosphoesters
that are generated by all other kinases and allows for an enrichment of thiophosphopeptides by immunoaffinity
purification. This study provides the foundation for using the analog-sensitive kinase method in the context of complex
vertebrate development, physiology, or disease.
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Introduction
Phosphorylation is a protein modification that is essential for
almost all aspects of cell biology. Kinases that catalyze this post-
translational modification are an abundant group of enzymes with
promiscuous substrate specificity and a common requirement for
ATP. For this reason, the identification of specific substrate
proteins of particular kinases has remained a tedious challenge and
traditionally involves in vitro phosphorylation assays with candidate
substrates. However, in vitro assays often generate false-positive
results and are inferior to in vivo screening conditions in which the
kinase of interest localizes within the correct subcellular compart-
ment and is associated with endogenous binding partners that
modulate its activity and affinity towards substrate proteins. The
analog-sensitive kinase method utilizes in vivo conditions for
substrate identification but has never been employed in a
multicellular model organism [1].
The atypical protein kinase C (aPKC) family consists of serine/
threonine kinases with essential cellular functions in cell polarity
and organ morphogenesis, cell migration, apoptosis and prolifer-
ation (reviewed in [2–5]). Increasing evidence also points at an
involvement of aPKCs in the promotion of carcinogenesis in vitro
and in vivo [reviewed in [6]]. Among other proteins, aPKCs are
core components of the apical Partition defective 6 (Pard6)-aPKC
protein complex which is composed of several PDZ domain
containing proteins and is required for the establishment of
epithelial apicobasal polarity in many systems (reviewed in [4,7]).
The unique N-terminal regulatory domain of aPKCs which
contains a Phox Bem1 (PB1) domain mediates direct interactions
with the polarity protein Pard6 which in turn modulates aPKC
activity, or with the small GTPases Rac1 and Cdc42 [8]. The
zebrafish heart and soul locus encodes Prkci, one of two aPKCs
expressed in this organism [9,10]. Consistent with a function in
apicobasal cell polarity, zebrafish mutants lacking Prkci show
defective formation and maintenance of several embryonic
epithelia and abnormal heart morphogenesis [9,11,12]. Prkci
function in cellular polarity and organ morphogenesis requires its
catalytic activity [12].
To date, only a small number of substrate proteins of Prkci in
the context of cellular polarity, proliferation control or apoptosis
have been identified in any organism, and the molecular
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mechanisms of their interaction with aPKCs have been convinc-
ingly demonstrated for only a few of them [13–19]. In addition to
its auto-phosphorylation [3], potentially relevant substrate proteins
of aPKC activity in the context of cellular polarity are Par3
[17,20,21], Numb [22,23], Miranda [24], Frizzled 1 [25], Partner
of inscuteable [26], and GSK-3b [8]. To further elucidate the
mechanistic relevance of aPKCs during development and in
various cell biological processes it is necessary to identify
phosphorylation targets in an unbiased manner and under in vivo
conditions.
We have established conditions for a chemical genetics screen
using the analog-sensitive kinase method to identify phosphoryla-
tion targets of Prkci during zebrafish development. This method-
ology opens the way for the identification and functional
characterization of specific substrates in their normal subcellular
context which is essential for a mechanistic understanding of how
Prkci affects divergent cellular processes.
Results
Design of an Analog-sensitive Prkci
We established a screening approach with the aim to identify
Prkci phosphorylation targets in a multicellular model organism.
The straightforward screening method using analog-sensitive
kinases utilizes an environment that is similar to the in vivo state
of the kinase. In principle, the method is based on engineering a
mutant kinase that accepts bulky ATP or ATPcS analogs such as
N6-benzyl ATP or N6-benzyl ATPcS. The ATP analog-sensitive
kinase is generated by replacing a large hydrophobic group within
the ATP binding pocket (the ‘‘gatekeeper’’ residue) with a smaller
residue thereby enlarging the binding pocket which allows the
kinase to accept bulkier ATP analogs (Fig. 1A). The specificity of
this approach has been demonstrated for various kinases, e.g. by
utilizing a modified v-Src, c-Raf-1, or AMPKa2 for the
identification of novel substrates [1,27,28].
To identify an ATP binding site ‘‘gatekeeper’’ residue within the
Prkci ATP binding pocket, we selected suitable residues for site-
directed mutagenesis based on the high evolutionary conservation
of the ATP binding site in different protein kinases, including v-Src
[1] and c-Raf-1 [28] that had successfully been engineered to
utilize N6-benzyl ATP. The comparison of the primary sequence
of Prkci, c-Src, and c-Raf-1 kinase domains suggested Val300 and
Ile316 of Prkci to be the most likely ‘‘gatekeeper’’ residues and
therefore to be the most suitable targets for site-directed
mutagenesis (Fig. 1B).
Mutant PrkciI316A has Normal in Vivo Biological Activity
One stringent requirement for an analog-sensitive kinase is the
conservation of its biological properties which includes normal in
vivo functionality and substrate specificity. We therefore tested
whether the PrkciV300A or PrkciI316A mutants with altered ATP
binding pockets had normal biological activity. Loss of Prkci has
well-characterized epithelial and organ morphogenesis defects that
involve cardiac malformations and a defective neuroepithelium
[9,11,12]. In functional rescue experiments, we co-injected at the
one-cell stage mRNA encoding either PrkciWT or one of the two
mutant Prkci proteins together with an antisense oligonucleotide
morpholino (MO) for knockdown of endogenous Prkci. Whereas
expression of PrkciI316A allowed normal cardiac development
(63% of prkci morphant embryos rescued, n= 183) which was
almost as efficient as PrkciWT expression (83% of prkci morphants
rescued, n= 166), the PrkciV300A mutant was not biologically
active based on the appearance of prkci morphant cardiac
phenotypes among all injected embryos (Fig. 2A) [9].
Because the PrkciI316A mutant was biologically fully functional
within the heart, we anticipated that this mutant kinase should
correctly localize within myocardial cells. Indeed, expression by
injection at the one-cell stage of mRNA encoding Myc-tagged
PrkciI316A resulted in the correct localization of the mutant protein
to the cell membrane, similar to Myc-tagged PrkciWT or
endogenous Prkci (Fig. 2B). That overexpression of PrkciWT or
PrkciI316A did not cause any ectopic phenotypes strongly suggests
substrate specificity (see below). Together, our results indicated
that PrkciI316A is biologically functional and predominantly
localizes to the correct subcellular compartment at the cell
membrane, which makes this mutant kinase a strong candidate
for a chemical genetic screen.
Mutant PrkciI316A can use Bulky ATP Analogs
We next tested whether PrkciI316A could utilize bulky ATP
analogs by assaying the phosphorylation efficiency and specificity
of several alkylated ATPcS analogs in in vitro kinase assays. ATPcS
was utilized instead of regular ATP to ensure a transfer of a
phosphorothioate moiety to the phosphoacceptor hydroxyl groups
of respective substrates. The substitution of sulfur in place of
oxygen generates unique thiophosphorylated epitopes that, when
alkylated with p-nitrobenzyl mesylate (PNBM), generate thiopho-
sphoester epitopes which can be recognized by a specific
monoclonal antibody [29,30]. Using the baculovirus system in
Sf9 insect cells, we produced the recombinant kinases and first
confirmed that PrkciWT and PrkciI316A could utilize ATPcS to
phosphorylate Myelin Basic Protein (MBP) as substrate and that
this modification could efficiently be detected with the anti-
thiophosphoester antibody (Fig. 3). However, whereas PrkciWT
accepted ATPcS, it could not utilize any of the tested N6-alkylated
ATPcS analogs (N6-benzyl-, N6-phenethyl-, or N6-cyclopentyl-
ATPcS) [30] as assessed on Western blot upon the in vitro kinase
assay. In contrast, PrkciI316A most efficiently utilized N6-benzyl
ATPcS (Fig. 3) whereas the other two bulky ATPcS analogs were
apparently not efficiently utilized (data not shown). Taken
together, PrkciI316A had a normal biological function in the in
vivo context and exerted catalytic activity using a bulky N6-benzyl-
ATP analog. Hence, PrkciI316A fulfilled the basic requirements
required to identify Prkci phosphorylation targets.
Figure 1. Design of the analog-sensitive Prkci. (A) A space-
creating mutation (‘‘gatekeeper mutation’’) is introduced into the kinase
ATP binding pocket which allows the analog-sensitive (AS) kinase
mutant to accept a bulky ATP analog (A*TP) required for the chemical
genetic identification of kinase substrates [modified after [36]]. (B)
Alignment of the primary sequence of the ATP binding pocket within
the kinase domains of Prkci, v-Src and c-Raf. The residues in red
correspond to the amino acids mutated in v-Src [1], c-Raf-1 [28], and
Prkci to enlarge the ATP binding pocket.
doi:10.1371/journal.pone.0040000.g001
Zebrafish Analog-Sensitive Prkci
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Evidence for PrkciI316A-mediated Thiophosphorylation in
the Zebrafish Embryo
Two principal methods have been used for the enrichment of
thiophosphorylated proteins in in vitro phosphorylation assays and
in cell culture systems but not yet in any model organism. The
‘‘covalent capture’’ approach is based on the enrichment of
thiophosphate-tagged substrates with iodoacetyl-agarose and
subsequent analysis by mass spectrometry [31]. An alternative
approach is based on ‘‘immunoaffinity purification’’ enrichment
using the anti-thiophosphoester antibody, followed by mass
spectrometry of enriched peptides [27,30]. Both methods require
the utilization of ATPcS analogs for the unique labelling of
substrate proteins.
One preeminent challenge of using ATPcS analogs in in vivo
approaches is the potential toxicity of thiophosphates since such
protein modifications cannot be removed by phosphatases. We
first tested the toxicity of N6-benzyl ATPcS analog by injecting
different concentrations (,1 nL injection volume) into wild-type
embryos and found that a concentration of 200 mM of N6-benzyl
ATPcS was the maximal concentration that could be injected into
one-cell stage embryos without affecting development (200 mM:
93.3% of embryos developed normally, n = 45; 250 mM: 47.8% of
embryos developed normally, n = 23; 500 mM: 37.2% of embryos
developed normally, n = 43). We next tested the feasibility of
applying this approach in the zebrafish embryo by optimizing the
conditions for introducing N6-benzyl ATPcS together with mRNA
encoding PrkciI316A by microinjection at the one-cell stage
(Fig. 4A). With the concentration of 200 mM N6-benzyl ATPcS
(,1 nL injection volume), we observed that most embryos survived
up to 32 hours post fertilization (hpf) (97.2% of PrkciI316A
Figure 2. Mutant PrkciI316A has normal in vivo biological activity. (A) Reconstruction of confocal Z-stack sections of embryonic hearts at 28–
30 hpf. Transgenic Tg[cmlc2:GFP]twu34 one-cell stage embryos were injected with prkci MO alone or together with mRNA encoding PrkciWT or analog-
sensitive mutant forms of Prkci. Whereas the wild-type heart elongates into a heart tube and towards the left during cardiac jogging, heart
development arrests at the cone stage and the heart remains at the embryonic midline in prkcimorphants. In functional rescue experiments, injection
of prkciMO together with mRNA encoding HisMyc-PrkciWT or PrkciI316A rescues heart tube elongation. In comparison, the analog-sensitive mutant
form PrkciV300A fails to rescue heart tube formation in prkci morphants. Percentiles indicate the occurrence of the most common phenotype as
depicted in the images and numbers show the total of embryos tested. White dotted line indicates the embryonic midline. L, left; R, right. (B)
Membrane localization of endogenous Prkci detected with an anti-Prkci antibody and exogenous PrkciWT or PrkciI316A in zebrafish cardiomyocytes
detected with an anti-Myc antibody. Images are confocal reconstructions of single Z-stack sections of embryonic hearts marked by the transgenic
reporter Tg[cmlc2:GFP]twu34 at 28–30 hpf. Expression of exogenous HisMyc-PrkciWT or HisMyc-PrkciI316A in cardiomyocytes reveals that both
recombinant proteins localize to the cell membrane.
doi:10.1371/journal.pone.0040000.g002
Figure 3. Mutant PrkciI316A uses bulky N6-benzyl ATPcS. Kinase
reaction with Myelin Basic Protein (MBP) and ATPcS or N6-benzyl ATPcS
(6-bn- ATPcS), followed by PNBM alkylation. In comparison, only mutant
PrkciI316A efficiently utilizes N6-benzyl ATPcS to thiophosphorylate MBP.
Labeled MBP is detected by Western blot analysis with rabbit
monoclonal anti-thiophosphoester antibody (a-thioP).
doi:10.1371/journal.pone.0040000.g003
Zebrafish Analog-Sensitive Prkci
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expressing embryos developed normally, n = 320), which was
comparable with embryos co-injected with N6-benzyl ATPcS and
mRNA encoding PrkciWT (96.5% of embryos developed normally,
n = 261), or with non-injected control embryos (96.7% of embryos
developed normally, n = 390). Therefore, N6-benzyl ATPcS in the
range of physiological ATP levels is compatible with normal
zebrafish embryogenesis.
To assess whether thiophosphorylation had occurred in the
developing zebrafish embryo, such in vivo thiophosphorylated 8 hpf
extracts were alkylated using PNBM, resolved by SDS-PAGE, and
Western blots probed with the anti-thiophosphoester antibody.
This analysis revealed that thiophosphorylation of substrates had
indeed occurred in the zebrafish embryo and that PrkciI316A had
catalyzed the selective labelling of at least one putative substrate
(Fig. 4B).
Discussion
This study outlines the methodology required for an in vivo
screening approach using an analog-sensitive kinase in a multi-
cellular model organism. Our work demonstrates the conditions
for in vivo thiophosphoester labeling of substrates using an analog-
sensitive kinase and bulky N6-benzyl ATPcS analogs. Injection of
physiological levels of bulky N6-benzyl ATPcS does not interfere
with zebrafish development even though thiophosphorylations are
largely irreversible. Viability of zebrafish embryos under such
conditions indicates that only a fraction of substrate proteins is
modified by the analog-sensitive kinase and such in vivo thiopho-
sphorylations are detectable on Western blots. That thiopho-
sphorylations are also detected in PrkciWT samples is due to
unspecific utilization of N6-benzyl ATPcS by other enzymes [31]
and to the partial degradation of N6-benzyl ATPcS to ATPcS
which can be utilized by other kinases. These contaminations with
unspecific thiophosphoylations highlight the need to immunopur-
ify embryonic extracts and to perform comparative mass
spectrometric analyses for substrate identification.
The method for the enrichment and identification of novel
putative kinase targets by immunoaffinity purification with an anti-
thiophosphoester antibody is well-established [27,30]. Combining
this methodology with the working protocol outlined in our study
will soon provide unprecedented insight into kinase signaling in
multi-tissue encompassing developmental processes, the regulation
of different physiological conditions, or in disease processes
involving aberrant kinase signaling. Taken together, our work
provides the ground for similar approaches using the analog-
sensitive kinase method in this and other multicellular model
organisms.
Materials and Methods
Fish Maintenance and Stocks
Zebrafish were maintained at standard conditions [32].
Embryos were kept in egg water (60 mg/ml Instant Ocean Sea
Salts, Aquarium Systems Inc., USA) and staged at 28.5uC [33].
The following fish strains were used: AB (wild-type),
Tg[cmlc2:GFP]twu34 [34].
Figure 4. Thiophosphorylation of substrate proteins by PrkciI316 in the zebrafish embryo. (A) Schematic diagram of the in vivo labeling
method for the selective labeling of PrkciI316A substrates during zebrafish development. (B) In vivo thiophosphorylation in zebrafish embryos injected
at the one-cell stage with 200 mM N6-benzyl-ATPcS (6-bn-ATPcS) and mRNA encoding either PrkciWT or PrkciI316A (AS). Western blot analysis with
rabbit monoclonal anti-thiophosphoester (a-thioP) C51-8 antibody (Epitomics) of 80% epiboly (6–8hpf) samples alkylated with 2.5 mM PNBM reveals
a selectively labeled protein in the PrkciI316A (AS) sample (asterisk).
doi:10.1371/journal.pone.0040000.g004
Zebrafish Analog-Sensitive Prkci
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RNA and Antisense Oligonucleotide Morpholino
Injections
Constructs were transcribed using the SP6 mMessage mMa-
chine kit (Ambion). Tg[cmlc2:GFP]twu34 embryos were injected with
2.5 ng of prkci MO [12]. For rescue experiments 100 pg of
mRNAs were injected. The heart morphology was assessed at
24hpf. Data presented are the means of at least 2 independent
experiments. For in vivo labeling, 200 pg of mRNA encoding
HisMyc-PrkciWT or HisMyc-PrkciI316A mRNA were injected at
the one-cell stage.
The antisense oligonucleotide morpholino was purchased from
Gene Tools, LLC, USA. prkci MO (59R 39):
TGTCCCGCAGCGTGGGCATTATGGA [12].
DNA Constructs and Site-directed Mutagenesis
Both constructs encoding wt and mutant forms of Prkci were
produced by PCR amplification from a full length cDNA
template, pCS2+ HisMyc::prkci [12]. Site directed mutagenesis
was performed using the QuickChangeTM XL Site-Directed
mutagenesis kit (Stratagene). Primer sequences are available upon
request.
Protein Extraction from Zebrafish Embryos
Zebrafish embryos protein extraction was performed as
previously described [35]. Embryos were dechorionated with
pronase solution in E2 medium in Petri dishes coated with 1%
agarose. After washes with E2 medium, embryos were transferred
to 1.5 ml tubes. The yolk was disrupted by pipetting with a 1 ml
pipet and vortexing for 30 seconds at 1100 rpm in deyolking
buffer. Embryos were pelleted several times after washes in
washing buffer at 3000 rpm for 30 seconds. Pelleted embryos were
homogenized in the appropriated lysis buffer depending on the
following experiment.
Recombinant Protein Expression in Insect Cells
To express recombinant PrckiWT or PrkciI316A in Sf9 insect cells
(Sigma), Bac-to-BacH Baculovirus Expression System (Invitrogen)
was used according to the manufacturers’ protocol. HisMyc::prk-
ciWT and HisMyc::prkciI316 cDNAs were cloned into pFastBacTM1.
Primer sequences are available upon request.
Whole-mount Immunohistochemistry and Confocal
Imaging
Whole-mount antibody stainings were performed as previously
described [9]. The following antibodies were used: rabbit anti-
aPKC (1:100, Santa Cruz SC-216), mouse anti-Myc (1:200,
Invitrogen), goat anti-rabbit RRX (1:250, Jackson ImmunoRe-
search Laboratories), goat anti-mouse Cy5 (1:250, Jackson
ImmunoResearch Laboratories). For imaging, samples were
embedded in SlowFadeH Gold antifade reagent (Invitrogen) under
a binocular microscope (Leica). Confocal images were obtained
with a Zeiss LSM 510 Meta confocal microscope using 40X or
63X objectives. Zeiss LSM 510 software was used to record
images. Images were processed using Photoshop (Adobe).
In vitro kinase Assay
For in vitro kinase assays 50 mg of MBP were incubated at 30uC
for 30 minutes with 5mg of recombinant HisMyc-PrckiWT or
HisMyc-PrkciI316A and 500 mM ATPcS or N6-benzyl ATPcS
(BioLog, B072-05) in kinase buffer [25mM Tris-HCl, pH 7.5,
25 mM NaCl, 10 mM MgCl2, 1 mM EGTA, protease inhibitor
cocktail (Roche)]. The other bulky ATP analogs (N6-phenethyl-
ATPcS, N6-cyclopentyl-ATPcS) were generated as described [30].
The kinase reaction was stopped by adding 4x SDS loading buffer
and boiling at 95uC for 5 minutes. Samples were analyzed by
Western blot using the following antibodies: mouse anti-Myc
(1:1000, Invitrogen), anti-thiophosphoester rabbit polyclonal
antibody (1:5000 Epitomics), rabbit anti-GAPDH (1:1000), goat
anti-mouse HRP (1:5000, Jackson ImmunoResearch), goat anti-
rabbit HRP (1:10000, Jackson ImmunoResearch).
In Vivo Thiophosphorylation in Zebrafish Embryos
For in vivo thiophosphorylation 200 pg of mRNA encoding
HisMyc-PrkciWT or HisMyc-PrkciI316A were injected into the yolk
at the one-cell stage together with approximately 1 nL of 200 mM
N6-benzyl ATPcS. Embryonic protein extracts were prepared at 8
hpf, and pelleted embryos were homogenized in RIPA buffer.
Alkylation was perfomed for 2 hours at RT with 2.5 mM PNBM
[30]. Samples were analyzed by Western blot using anti-thiopho-
sphoester rabbit monoclonal C51-8 antibody (1:5000 Epitomics).
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